Anika Therapeutics Inc..
ANIK.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Anika Therapeutics, Inc. is a global medical technology company that develops, manufactures, and commercializes therapeutic solutions based on hyaluronic acid (HA). The company's products are used in joint preservation, restoration, and regenerative solutions, primarily for the treatment of osteoart...Show More
Better Health for All
0
Anika Therapeutics' core business is developing therapeutic solutions based on hyaluronic acid for joint preservation, restoration, and regenerative solutions, primarily for osteoarthritis.
1
Products like Monovisc, Orthovisc, Cingal, and Hyalofast are described as providing pain relief for up to six months, requiring fewer office visits, having lower treatment costs, and involving no downtime, indicating exceptional health benefits.
2
There is no evidence of the company generating revenue from products with well-established negative health outcomes.
3
For Monovisc, warnings regarding pregnancy, breastfeeding, elderly patients, allergies, and drug interactions are included, along with a list of common and rare side effects such as joint pain, inflammation, rash, and headache.
4
Fair Money & Economic Opportunity
0
Anika Therapeutics Inc. is a medical technology company focused on therapeutic solutions.
1
The provided articles discuss the company's stock performance, financial results, and equity incentive programs. None of the articles contain any specific, concrete data points or information related to financial services, lending practices, or economic opportunity initiatives. Therefore, no KPIs under the 'Fair Money & Economic Opportunity' value can be scored based on the evidence provided, as the company's core business does not involve financial services.
Fair Pay & Worker Respect
0
No evidence available to assess Anika Therapeutics Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No evidence available to assess Anika Therapeutics Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
-10
Anika Therapeutics Inc. incurred $10,500 in ethics-related regulatory fines in the past three years, specifically a workplace safety or health violation in 2025.
1
The company has a comprehensive Whistleblower Policy, effective August 30, 2016, which applies to all employees and the board, includes a non-retaliation clause, and provides anonymous reporting channels (hotline and online system).
2
The company has had zero financial restatements in the past five years, with a filing indicating no corrections to previously issued financial statements.
3
Anika has a comprehensive anti-corruption policy, including compliance with the Foreign Corrupt Practices Act, and conducts annual training with risk assessments and third-party due diligence.
4
The median time to close ethics complaints is generally within 60 days.
5
Kind to Animals
-40
Anika Therapeutics tests medical devices on animals, specifically rats.
1
The company does not disclose the number of animals used annually or provide transparent reduction targets.
2
However, several of its core products, including Monovisc, Orthovisc, Cingal, and the Integrity implant, utilize non-animal sourced hyaluronic acid or substitute animal-derived materials with semi-synthetic alternatives.
3
This indicates that at least 50% of its product inputs are ethical alternatives.
No War, No Weapons
0
No evidence available to assess Anika Therapeutics Inc. on No War, No Weapons.
Planet-Friendly Business
0
No evidence available to assess Anika Therapeutics Inc. on Planet-Friendly Business.
Respect for Cultures & Communities
0
Anika Therapeutics has no reported cultural appropriation incidents.
1
The company's 10-K filings from 2026 and 2025 do not mention any such incidents.
2
Safe & Smart Tech
10
The company has an ongoing mandatory cybersecurity training program for all employees, which includes routine attack simulations.
1
It conducts penetration testing and vulnerability assessments as part of its cybersecurity risk management program, and performs periodic security assessments in collaboration with key stakeholders.
2
The company states it has taken steps to comply with the GDPR, including reviewing security procedures and entering into data processing agreements with service providers.
3
It is subject to various data privacy laws including GDPR, UK GDPR, CCPA, CPRA, and Washington’s My Health My Data Act.
4
Zero Waste & Sustainable Products
0
No evidence available to assess Anika Therapeutics Inc. on Zero Waste & Sustainable Products.